Evidence map›Paper›PMID 30367471›Full record

Trial reportThe British journal of dermatology2019

Diverse assays from a single skin punch biopsy to assess topical drug intervention.

M Danilenko, K Hodgson, R Stones, A Husain, M Zangarini, G Veal, N Rajan

Open access · hybridAbstract readLetterRandomized Controlled Trial
PubMed Full text at PMC Publisher
In one paragraph

Trial report in The British journal of dermatology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact, top 81% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

M DanilenkoInstitute of Genetic Medicine, Newcastle University, Newcastle upon Tyne, U.K.
K HodgsonInstitute of Genetic Medicine, Newcastle University, Newcastle upon Tyne, U.K.
R StonesInstitute of Genetic Medicine, Newcastle University, Newcastle upon Tyne, U.K.
A HusainDepartment of Pathology, Royal Victoria Infirmary, Newcastle upon Tyne, U.K.
M ZangariniNorthern Institute for Cancer Research, Newcastle University, Newcastle upon Tyne, U.K.
G VealNorthern Institute for Cancer Research, Newcastle University, Newcastle upon Tyne, U.K.
N RajanInstitute of Genetic Medicine, Newcastle University, Newcastle upon Tyne, U.K.ORCID 0000-0002-5850-5680
Newcastle University · GBRoyal Victoria Infirmary · GB

Funding

Department of Health 100935/Z/13/ZWellcome TrustWellcome Trust WT097163MA
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Administration, CutaneousAdultBiological AssayBiopsyDiscoidin Domain Receptor 2Gene Expression Regulation, NeoplasticHeterocyclic Compounds, 4 or More RingsHumansMembrane GlycoproteinsNeoplastic Syndromes, HereditaryProof of Concept StudyReceptor, trkBSkinSkin NeoplasmsDDR2 protein, humanDiscoidin Domain Receptor 2Heterocyclic Compounds, 4 or More RingsMembrane GlycoproteinspegcantratinibReceptor, trkBtropomyosin-related kinase-B, human

Identifiers

PMID30367471
PMCPMC6487947
OpenAlexW2898564085

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.